Seelos Therapeutics (SEEL) just unveiled an update.
Seelos Therapeutics, Inc. has announced an upcoming reverse split of its common stock, aiming to make a strategic move in the market. This decision is detailed in their latest press release, which investors might find of significant interest, as it could affect stock value and ownership.
For a thorough assessment of SEEL stock, go to TipRanks’ Stock Analysis page.
